Connor, Clark & Lunn Investment Management (CC&L)’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
Connor, Clark & Lunn Investment Management (CC&L)'s PBH Position: Q4 2024 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of Prestige Consumer Healthcare (PBH) in Q4 2024, closing a stake of 7,319 shares — an estimated $528K sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PBH in Q1 2014 and held it in 14 quarters. The position peaked at $2.26M in Q2 2022. 336 funds tracked by Wall St. Rank hold PBH as of Q4 2024.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Prestige Consumer Healthcare position as of Q4 2024 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 7,319 Prestige Consumer Healthcare shares in Q4 2024, an estimated $528K.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Prestige Consumer Healthcare in Q1 2014 and held it in 14 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s Prestige Consumer Healthcare position peaked at $2.26M in Q2 2022.
- 336 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2024.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2024, filed 10 Feb 2025.